US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval
www.scmp.com
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
  • ramble81
    9·
    1 year ago

    Cheap R&D overseas and reap the profits in the US. It’s the new norm for capitalism